To perfect the treatment of CKD, several modern medicines, such as angiotensin-receptor blockers (ARBs), mineralocorticoid-receptor antagonists, sodium/glucose cotransporter 2 (SGLT2), beta-blockers, and anti-fibrotic, as well as anti-inflammatory drugs, have been utilized. The gene discussed is SLC5A2; the disease is chronic kidney disease.